Veteran UFC Campaigner C.B. Dollaway’s long run in the promotion has come to end as he’s just signed a new deal with Japanese promotion Rizin.
Earlier this year Dollaway was suspended for two years by USADA, backdated to December of 2018 where it was revealed the fighter had tested positive for the growth hormone anastrozole as well as GHRP-2 and GHRP-6 in an out-of-competition test, in addition to also having received an over-the-limit IV.
Along with that Dollaway was also found to have tested positive for clomiphene in February of this year.
However, by joining Rizin, the 36-year-old Dollaway can circumnavigate the ban since Rizin doesn’t recognize bans handed out by a drug-testing agency like USADA.
Dollaway was coming off a TKO loss to Khalid Murtazaliev back in September of 2018, which had ended a two-fight winning streak against Ed Herman and Hector Lombard.
In total, Dollaway fought 20 times for the UFC after being recruited as a finalist on TUF Season 7, delivering an 11-9 record inside the Octagon.
Now Dollaway is heading straight into a big fight in Rizin as he’s been lined up for a light-heavyweight title challenge against current champion Jiri Prochazka, who is currently on a nine-fight winning streak that includes victories over the likes of Muhammed ‘King Mo’ Lawal and Fabio Maldonado.